CYSLTR1 and Allergy: We have previously investigated the role of polymorphic variation in the genes of the 5-lipoxygenase pathway e.g. ALOX5, LTC4S, CYSLTR1 in asthma and allergy susceptibility [15,19,20] and as determinants of clinical responses to therapies targeting this pathway [21].